ANXA2 and cancer: HSP90 has been described as abundantly secreted by organoids with cancer stem cell-like properties [62]; annexin II is also implicated in the metastatic process [63], and its expression in numerous cancers correlates with resistance to treatment, binding to the bone marrow, histological grade and type, TNM stage, and shortened overall survival, as discussed in a recent review [64].